{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:07:24Z","timestamp":1789607244717,"version":"build-2803163510"},"reference-count":130,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Wroclaw Medical University","award":["SUBK.C260.23.037"],"award-info":[{"award-number":["SUBK.C260.23.037"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIMB"],"abstract":"<jats:p>This manuscript explores the role of pyroptosis, an inflammatory programmed cell death, in the pathogenesis of two chronic dermatoses, psoriasis and hidradenitis suppurativa (HS). The diseases, though clinically diverse, share common pathogenetic pathways involving the unbalanced interaction between the adaptive and innate immune systems. This review focuses on the molecular changes in psoriatic and HS skin, emphasizing the activation of dendritic cells, secretion of interleukins (IL-17, IL-22, and TNF-\u03b1), and the involvement of inflammasomes, particularly NLRP3. This manuscript discusses the role of caspases, especially caspase-1, in driving pyroptosis and highlights the family of gasdermins (GSDMs) as key players in the formation of pores leading to cell rupture and the release of proinflammatory signals. This study delves into the potential therapeutic implications of targeting pyroptosis in psoriasis and HS, examining existing medications like biologics and Janus kinase inhibitors. It also reviews the current limitations and challenges in developing therapies that selectively target pyroptosis. Additionally, the manuscript explores the role of pyroptosis in various inflammatory disorders associated with psoriasis and HS, such as inflammatory bowel disease, diabetes mellitus, and cardiovascular disorders. The review concludes by emphasizing the need for further research to fully elucidate the pathomechanisms of these dermatoses and develop effective, targeted therapies.<\/jats:p>","DOI":"10.3390\/cimb46010043","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T06:52:14Z","timestamp":1704955934000},"page":"663-676","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pathological and Therapeutical Implications of Pyroptosis in Psoriasis and Hidradenitis Suppurativa: A Narrative Review"],"prefix":"10.3390","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4722-8531","authenticated-orcid":false,"given":"Piotr","family":"Krajewski","sequence":"first","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Chalubinskiego 1, 50-368 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tsoukas","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Illinois at Chicago, Chicago, IL 60607, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0766-6342","authenticated-orcid":false,"given":"Jacek","family":"Szepietowski","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Chalubinskiego 1, 50-368 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Sawada, Y., Saito-Sasaki, N., Mashima, E., and Nakamura, M. (2021). Daily Lifestyle and Inflammatory Skin Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22105204"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1208817","DOI":"10.3389\/fmed.2023.1208817","article-title":"Hidradenitis suppurativa and psoriasis: The odd couple","volume":"10","author":"Macca","year":"2023","journal-title":"Front. Med."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Lelonek, E., Bouazzi, D., Jemec, G.B.E., and Szepietowski, J.C. (2023). Skin and Gut Microbiome in Hidradenitis Suppurativa: A Systematic Review. Biomedicines, 11.","DOI":"10.3390\/biomedicines11082277"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/bjd\/ljac107","article-title":"Adipokines as an important link between hidradenitis suppurativa and obesity: A narrative review","volume":"188","author":"Krajewski","year":"2023","journal-title":"Br. J. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"103169","DOI":"10.1016\/j.autrev.2022.103169","article-title":"Psoriasis: Interplay between dysbiosis and host immune system","volume":"21","author":"Kapoor","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-020-0149-1","article-title":"Hidradenitis suppurativa","volume":"6","author":"Sabat","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.26444\/aaem\/112107","article-title":"Environmental risk factors and epigenetic alternations in psoriasis","volume":"27","author":"Roszkiewicz","year":"2020","journal-title":"Ann. Agric. Environ. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Motolese, A., Ceccarelli, M., Macca, L., Pomi, F.L., Ingrasciotta, Y., Nunnari, G., and Guarneri, C. (2022). Novel Therapeutic Approaches to Psoriasis and Risk of Infectious Disease. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020228"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jaad.2019.08.090","article-title":"Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis","volume":"82","author":"Goldburg","year":"2020","journal-title":"J. Am. Acad Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"20406223211055920","DOI":"10.1177\/20406223211055920","article-title":"New perspectives on the treatment of hidradenitis suppurativa","volume":"12","author":"Vilarrasa","year":"2021","journal-title":"Ther. Adv. Chronic Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"adv00698","DOI":"10.2340\/actadv.v102.563","article-title":"Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data","volume":"102","author":"Gottlieb","year":"2022","journal-title":"Acta Derm. Venereol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(23)00022-3","article-title":"Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): Week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials","volume":"401","author":"Kimball","year":"2023","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ketelut-Carneiro, N., and Fitzgerald, K.A. (2022). Apoptosis, Pyroptosis, and Necroptosis-Oh My! The Many Ways a Cell Can Die. J. Mol. Biol., 434.","DOI":"10.1016\/j.jmb.2021.167378"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrm3737","article-title":"Regulated necrosis: The expanding network of non-apoptotic cell death pathways","volume":"15","author":"Berghe","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature14191","article-title":"Necroptosis and its role in inflammation","volume":"517","author":"Pasparakis","year":"2015","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/358167a0","article-title":"Shigella flexneri induces apoptosis in infected macrophages","volume":"358","author":"Zychlinsky","year":"1992","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0966-842X(00)01936-3","article-title":"Pro-inflammatory programmed cell death","volume":"9","author":"Cookson","year":"2001","journal-title":"Trends Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.immuni.2019.08.005","article-title":"Inflammasomes: Threat-Assessment Organelles of the Innate Immune System","volume":"51","author":"Evavold","year":"2019","journal-title":"Immunity"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/bjd.14214","article-title":"Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa","volume":"174","author":"Lima","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000502026","article-title":"The P2X7 Receptor Is Overexpressed in the Lesional Skin of Subjects Affected by Hidradenitis Suppurativa: A Preliminary Study","volume":"237","author":"Manfredini","year":"2021","journal-title":"Dermatology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/bjd\/ljad184","article-title":"Targeting the NLRP3 inflammasome reduces inflammation in hidradenitis suppurativa skin","volume":"189","author":"Moran","year":"2023","journal-title":"Br. J. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.mib.2013.04.004","article-title":"Inflammasome-mediated pyroptotic and apoptotic cell death, and defense against infection","volume":"16","author":"Aachoui","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/imr.12908","article-title":"Therapeutic modulation of inflammasome pathways","volume":"297","author":"Chauhan","year":"2020","journal-title":"Immunol. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nature15541","article-title":"Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling","volume":"526","author":"Kayagaki","year":"2015","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature13683","article-title":"Inflammatory caspases are innate immune receptors for intracellular LPS","volume":"514","author":"Shi","year":"2014","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"eaav1447","DOI":"10.1126\/sciimmunol.aav1447","article-title":"Gasdermin D activity in inflammation and host defense","volume":"4","author":"Lieberman","year":"2019","journal-title":"Sci. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e98321","DOI":"10.15252\/embj.201798321","article-title":"Mechanism of membrane pore formation by human gasdermin-D","volume":"37","author":"Mulvihill","year":"2018","journal-title":"EMBO J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.15252\/embj.201694696","article-title":"GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death","volume":"35","author":"Sborgi","year":"2016","journal-title":"EMBO J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature09447","article-title":"Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling","volume":"467","author":"Ghoreschi","year":"2010","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jid.2018.07.025","article-title":"A Critical Role of the IL-1beta-IL-1R Signaling Pathway in Skin Inflammation and Psoriasis Pathogenesis","volume":"139","author":"Cai","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jid.2018.11.018","article-title":"The IL-1 Pathway Is Hyperactive in Hidradenitis Suppurativa and Contributes to Skin Infiltration and Destruction","volume":"139","author":"Wolk","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.immuni.2017.11.013","article-title":"The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 Secretion from Living Macrophages","volume":"48","author":"Evavold","year":"2018","journal-title":"Immunity"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.4049\/jimmunol.1000803","article-title":"Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia","volume":"185","author":"Lamkanfi","year":"2010","journal-title":"J. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41418-018-0106-7","article-title":"Single-cell analysis of pyroptosis dynamics reveals conserved GSDMD-mediated subcellular events that precede plasma membrane rupture","volume":"26","author":"Parthoens","year":"2019","journal-title":"Cell Death Differ."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000283688","article-title":"Inflammatory caspases in innate immunity and inflammation","volume":"2","author":"Yazdi","year":"2010","journal-title":"J. Innate Immun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.immuni.2019.05.020","article-title":"Caspases in Cell Death, Inflammation, and Disease","volume":"50","author":"Lamkanfi","year":"2019","journal-title":"Immunity"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/bjd.14075","article-title":"Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa","volume":"173","author":"Kelly","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/exd.13919","article-title":"Matrix remodelling and MMP expression\/activation are associated with hidradenitis suppurativa skin inflammation","volume":"28","author":"Sanchez","year":"2019","journal-title":"Exp. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1038\/sj.jid.5700922","article-title":"The activity of caspase-1 is increased in lesional psoriatic epidermis","volume":"127","author":"Johansen","year":"2007","journal-title":"J. Investig. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/jid.2010.370","article-title":"Caspase-5 expression is upregulated in lesional psoriatic skin","volume":"131","author":"Johansen","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.3389\/fimmu.2019.02538","article-title":"Pharmacological Inhibitors of the NLRP3 Inflammasome","volume":"10","author":"Zahid","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"8041","DOI":"10.1073\/pnas.0611496104","article-title":"Cryopyrin\/NALP3 binds ATP\/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling","volume":"104","author":"Duncan","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.it.2019.09.005","article-title":"Emerging Activators and Regulators of Inflammasomes and Pyroptosis","volume":"40","author":"Xue","year":"2019","journal-title":"Trends Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: Molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"105885","DOI":"10.1016\/j.phrs.2021.105885","article-title":"NLRP3 inflammasome and IL-1\u03b2 pathway in type 2 diabetes and atherosclerosis: Friend or foe?","volume":"173","author":"Chen","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"963291","DOI":"10.3389\/fimmu.2022.963291","article-title":"Inflammasome-targeting natural compounds in inflammatory bowel disease: Mechanisms and therapeutic potential","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bbrc.2023.06.072","article-title":"Sodium thiosulfate ameliorates atopic dermatitis via inhibiting the activation of NLRP3 inflammasome","volume":"673","author":"Wang","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"7909","DOI":"10.12659\/MSM.911347","article-title":"Expression of NLPR3 in Psoriasis Is Associated with Enhancement of Interleukin-1beta and Caspase-1","volume":"24","author":"Su","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1042\/CS20160645","article-title":"BAY 11-7082 inhibits the NF-kappaB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis","volume":"131","author":"Irrera","year":"2017","journal-title":"Clin. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Chen, X., Chen, Y., Ou, Y., Min, W., Liang, S., Hua, L., and Sun, P. (2022). Bortezomib inhibits NLRP3 inflammasome activation and NF-\u03baB pathway to reduce psoriatic inflammation. Biochem. Pharmacol., 206.","DOI":"10.1016\/j.bcp.2022.115326"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Shih, M.-C., Li, C.-L., Liao, E.-C., Yen, C.-Y., Yen, L.-J., Wang, K.-C., Lu, L.-Y., Chou, T.-Y., Chen, Y.-C., and Yu, S.-J. (2023). Inhibition of NLRP3 Inflammasome Activation by 3H-1,2-Dithiole-3-Thione: A Potential Therapeutic Approach for Psoriasis Treatment. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241713528"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Mao, J., Ma, X., Zhu, J., and Zhang, H. (2022). Ginsenoside Rg1 ameliorates psoriasis-like skin lesions by suppressing proliferation and NLRP3 inflammasomes in keratinocytes. J. Food Biochem., 46.","DOI":"10.1111\/jfbc.14053"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.jid.2022.01.010","article-title":"Quinolinic Acid, a Tryptophan Metabolite of the Skin Microbiota, Negatively Regulates NLRP3 Inflammasome through AhR in Psoriasis","volume":"142","author":"Qiao","year":"2022","journal-title":"J. Investig. Dermatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2147\/TACG.S319065","article-title":"Evaluation of NLRP3 (rs10754558) and PTPN22 (1858C\/T) (rs2476601) Functional Polymorphisms in Psoriasis Susceptibility in Egypt","volume":"14","author":"Alrefai","year":"2021","journal-title":"Appl. Clin. Genet."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ygeno.2007.01.003","article-title":"Members of a novel gene family, Gsdm, are expressed exclusively in the epithelium of the skin and gastrointestinal tract in a highly tissue-specific manner","volume":"89","author":"Tamura","year":"2007","journal-title":"Genomics"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Xia, S., Hollingsworth, L.R., and Wu, H. (2020). Mechanism and Regulation of Gasdermin-Mediated Cell Death. Cold Spring Harb. Perspect. Biol., 12.","DOI":"10.1101\/cshperspect.a036400"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature18590","article-title":"Pore-forming activity and structural autoinhibition of the gasdermin family","volume":"535","author":"Ding","year":"2016","journal-title":"Nature"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/eji.201747404","article-title":"The Gasdermin-D pore acts as a conduit for IL-1\u03b2 secretion in mice","volume":"48","author":"Heilig","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1111\/j.1462-5822.2006.00751.x","article-title":"Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages","volume":"8","author":"Fink","year":"2006","journal-title":"Cell Microbiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature18629","article-title":"Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores","volume":"535","author":"Liu","year":"2016","journal-title":"Nature"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature22393","article-title":"Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin","volume":"547","author":"Wang","year":"2017","journal-title":"Nature"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"14128","DOI":"10.1038\/ncomms14128","article-title":"Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic\/pyroptotic cell death","volume":"8","author":"Rogers","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.bbrc.2017.11.156","article-title":"GSDME mediates caspase-3-dependent pyroptosis in gastric cancer","volume":"495","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Nowowiejska, J., Baran, A., Hermanowicz, J.M., Pryczynicz, A., Sieklucka, B., Pawlak, D., and Flisiak, I. (2023). Gasdermin D (GSDMD) Is Upregulated in Psoriatic Skin-A New Potential Link in the Pathogenesis of Psoriasis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241713047"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41419-023-06094-3","article-title":"Gasdermin D-mediated keratinocyte pyroptosis as a key step in psoriasis pathogenesis","volume":"14","author":"Lian","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Nowowiejska, J., Baran, A., Pryczynicz, A., Hermanowicz, J.M., Sieklucka, B., Pawlak, D., and Flisiak, I. (2023). Gasdermin E (GSDME)-A New Potential Marker of Psoriasis and Its Metabolic Complications: The First Combined Study on Human Serum, Urine and Tissue. Cells, 12.","DOI":"10.3390\/cells12172149"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Ji, X., Chen, H., Xie, L., Chen, S., Huang, S., Tan, Q., Yang, H., Yang, T., Ye, X., and Zeng, Z. (2023). The study of GSDMB in pathogenesis of psoriasis vulgaris. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0279908"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.smim.2013.10.018","article-title":"Interleukin-1\u03b2 in innate inflammation, autophagy and immunity","volume":"25","author":"Joosten","year":"2013","journal-title":"Semin. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fimmu.2013.00289","article-title":"Interleukin-18 and IL-18 binding protein","volume":"4","author":"Dinarello","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","article-title":"Pyroptosis: Mechanisms and diseases","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/bjd.21704","article-title":"Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: A cohort study: Classification: Epidemiology","volume":"187","author":"Schneeweiss","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000527422","article-title":"New and Emerging Treatments for Inflammatory Bowel Disease","volume":"104","author":"Higashiyama","year":"2023","journal-title":"Digestion"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/exd.14338","article-title":"Target molecules for future hidradenitis suppurativa treatment","volume":"30","author":"Zouboulis","year":"2021","journal-title":"Exp. Dermatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jaad.2020.07.087","article-title":"Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures","volume":"84","author":"Elmets","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1084\/jem.20151613","article-title":"Pyroptosis triggers pore-induced intracellular traps (PITs) that capture bacteria and lead to their clearance by efferocytosis","volume":"213","author":"Jorgensen","year":"2016","journal-title":"J. Exp. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13045-020-00985-0","article-title":"HMGB1 released from GSDME-mediated pyroptotic epithelial cells participates in the tumorigenesis of colitis-associated colorectal cancer through the ERK1\/2 pathway","volume":"13","author":"Tan","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"109265","DOI":"10.1016\/j.celrep.2021.109265","article-title":"Gasdermin-E-mediated pyroptosis participates in the pathogenesis of Crohn\u2019s disease by promoting intestinal inflammation","volume":"35","author":"Tan","year":"2021","journal-title":"Cell Rep."},{"key":"ref_82","first-page":"4218","article-title":"Epithelial-derived gasdermin D mediates nonlytic IL-1beta release during experimental colitis","volume":"130","author":"Bulek","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41419-019-2157-1","article-title":"NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-\u03baB signaling","volume":"10","author":"Chen","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/nature16959","article-title":"NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux","volume":"530","author":"He","year":"2016","journal-title":"Nature"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"eaaz6717","DOI":"10.1126\/sciadv.aaz6717","article-title":"Gasdermin D in macrophages restrains colitis by controlling cGAS-mediated inflammation","volume":"6","author":"Ma","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2017.08.042","article-title":"Hidradenitis suppurativa and diabetes mellitus: A systematic review and meta-analysis","volume":"78","author":"Bui","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: Epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fimmu.2017.00164","article-title":"Mitochondrial DNA Activates the NLRP3 Inflammasome and Predisposes to Type 1 Diabetes in Murine Model","volume":"8","author":"Carlos","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/ni.2022","article-title":"Fatty acid\u2013induced NLRP3-ASC inflammasome activation interferes with insulin signaling","volume":"12","author":"Wen","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.immuni.2013.05.015","article-title":"Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation","volume":"38","author":"Yan","year":"2013","journal-title":"Immunity"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"768029","DOI":"10.3389\/fcvm.2021.768029","article-title":"MiR-17-5p Inhibits TXNIP\/NLRP3 Inflammasome Pathway and Suppresses Pancreatic beta-Cell Pyroptosis in Diabetic Mice","volume":"8","author":"Liu","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"An, X., Zhang, Y., Cao, Y., Chen, J., Qin, H., and Yang, L. (2020). Punicalagin Protects Diabetic Nephropathy by Inhibiting Pyroptosis Based on TXNIP\/NLRP3 Pathway. Nutrients, 12.","DOI":"10.3390\/nu12051516"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2337\/db12-0420","article-title":"Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes","volume":"62","author":"Lee","year":"2013","journal-title":"Diabetes"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/bjd.14024","article-title":"Cardiovascular disease risk factors in patients with hidradenitis suppurativa: A systematic review and meta-analysis of observational studies","volume":"173","author":"Tzellos","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"109937","DOI":"10.1016\/j.ecoenv.2019.109937","article-title":"ROS-induced NLRP3 inflammasome priming and activation mediate PCB 118- induced pyroptosis in endothelial cells","volume":"189","author":"Long","year":"2020","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/FJC.0000000000000550","article-title":"Low-dose Sinapic Acid Abates the Pyroptosis of Macrophages by Downregulation of lncRNA-MALAT1 in Rats With Diabetic Atherosclerosis","volume":"71","author":"Han","year":"2018","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"111847","DOI":"10.1016\/j.yexcr.2020.111847","article-title":"VX-765 attenuates atherosclerosis in ApoE deficient mice by modulating VSMCs pyroptosis","volume":"389","author":"Li","year":"2020","journal-title":"Exp. Cell Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.intimp.2018.12.028","article-title":"Role of pyroptosis in cardiovascular diseases","volume":"67","author":"Jia","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"897815","DOI":"10.3389\/fcvm.2022.897815","article-title":"Pyroptosis: Role and Mechanisms in Cardiovascular Disease","volume":"9","author":"Chen","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e12449","DOI":"10.1111\/jpi.12449","article-title":"Melatonin prevents endothelial cell pyroptosis via regulation of long noncoding RNA MEG3\/miR-223\/NLRP3 axis","volume":"64","author":"Zhang","year":"2018","journal-title":"J. Pineal. Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"5702103","DOI":"10.1155\/2018\/5702103","article-title":"NLRP3: A Novel Mediator in Cardiovascular Disease","volume":"2018","author":"Zhou","year":"2018","journal-title":"J. Immunol. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.03.024","article-title":"Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis","volume":"24","author":"Shi","year":"2015","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1038\/cddis.2011.18","article-title":"Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome","volume":"2","author":"Menu","year":"2011","journal-title":"Cell Death Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.ATV.0000064374.15232.C3","article-title":"Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice","volume":"23","author":"Kirii","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1172\/JCI43713","article-title":"Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice","volume":"122","author":"Alexander","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.bcp.2013.03.008","article-title":"A novel benzo[d]imidazole derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of NLRP3 inflammasome","volume":"85","author":"Liu","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1021\/acschemneuro.7b00124","article-title":"Development and Characterization of a Hydroxyl-Sulfonamide Analogue, 5-Chloro-N-[2-(4-hydroxysulfamoyl-phenyl)-ethyl]-2-methoxy-benzamide, as a Novel NLRP3 Inflammasome Inhibitor for Potential Treatment of Multiple Sclerosis","volume":"8","author":"Guo","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"10161","DOI":"10.1158\/0008-5472.CAN-10-1921","article-title":"The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells","volume":"70","author":"Burgents","year":"2010","journal-title":"Cancer Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1158\/0008-5472.CAN-12-0509","article-title":"NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases","volume":"72","author":"Chow","year":"2012","journal-title":"Cancer Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.jaad.2022.07.065","article-title":"Anakinra for refractory pustular psoriasis: A phase II, open-label, dose-escalation trial","volume":"87","author":"Naik","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13063-020-4103-z","article-title":"A randomised placebo controlled trial of anakinra for treating pustular psoriasis: Statistical analysis plan for stage two of the APRICOT trial","volume":"21","author":"Cro","year":"2020","journal-title":"Trials"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/bjd.13012","article-title":"Partial clinical response to anakinra in severe palmoplantar pustular psoriasis","volume":"171","author":"Tauber","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1186\/s13063-018-2841-y","article-title":"A small population, randomised, placebo-controlled trial to determine the efficacy of anakinra in the treatment of pustular psoriasis: Study protocol for the APRICOT trial","volume":"19","author":"Cornelius","year":"2018","journal-title":"Trials"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"191","DOI":"10.55563\/clinexprheumatol\/mjt9x1","article-title":"Anakinra-induced psoriasis in a patient with Schnitzler\u2019s syndrome","volume":"40","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1365-2133.2008.08470.x","article-title":"New-onset psoriasis following treatment with the interleukin-1 receptor antagonist anakinra","volume":"158","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/bjd.14685","article-title":"Successful response in a case of severe pustular psoriasis after interleukin-1\u03b2 inhibition","volume":"176","author":"Skendros","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jamadermatol.2015.3903","article-title":"Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical Trial","volume":"152","author":"Tzanetakou","year":"2016","journal-title":"JAMA Dermatol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jaad.2013.09.044","article-title":"An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa","volume":"70","author":"Leslie","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jamadermatol.2013.5377","article-title":"Successful treatment of severe hidradenitis suppurativa with anakinra","volume":"149","author":"Zarchi","year":"2013","journal-title":"JAMA Dermatol."},{"key":"ref_122","first-page":"e208","article-title":"Long-term therapy with anakinra in hidradenitis suppurativa in three patients","volume":"58","author":"Marescassier","year":"2019","journal-title":"Int. J. Dermatol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00105-020-04703-2","article-title":"Anakinra therapy in a patient with multifocal pyoderma gangrenosum and hidradenitis suppurativa","volume":"72","author":"Oymanns","year":"2021","journal-title":"Hautarzt"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/bjd.13292","article-title":"Two cases of severe hidradenitis suppurativa with failure of anakinra therapy","volume":"172","author":"Menis","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_125","first-page":"772","article-title":"Failure of Anakinra in a Case of Severe Hidradenitis Suppurativa","volume":"15","author":"Russo","year":"2016","journal-title":"J. Drugs Dermatol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1684\/ejd.2013.2018","article-title":"Pyoderma gangrenosum and concomitant hidradenitis suppurativa--rapid response to canakinumab (anti-IL-1\u03b2)","volume":"23","author":"Jaeger","year":"2013","journal-title":"Eur. J. Dermatol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/jamadermatol.2017.2392","article-title":"Canakinumab for Severe Hidradenitis Suppurativa: Preliminary Experience in 2 Cases","volume":"153","author":"Houriet","year":"2017","journal-title":"JAMA Dermatol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"edth15002","DOI":"10.1111\/dth.15002","article-title":"Severe hidradenitis suppurativa (acne inversa) associated with focal segmental glomerulosclerosis and gout partially responsive to canakinumab","volume":"34","author":"Akdogan","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"615","DOI":"10.4103\/ijdvl.IJDVL_147_16","article-title":"Hidradenitis suppurativa unresponsive to canakinumab treatment: A case report","volume":"83","author":"Tekin","year":"2017","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_130","first-page":"36","article-title":"Non-response to Interleukin-1 Antagonist Canakinumab in Two Patients with Refractory Pyoderma Gangrenosum and Hidradenitis Suppurativa","volume":"10","author":"Sun","year":"2017","journal-title":"J. Clin. Aesthet. Dermatol."}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/46\/1\/43\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:44:24Z","timestamp":1760103864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/46\/1\/43"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":130,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["cimb46010043"],"URL":"https:\/\/doi.org\/10.3390\/cimb46010043","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,11]]}}}